MDFA News

New Nutrition Guidelines for AMD

Latest research supports Mediterranean and Asian-style eating plans to reduce risk of AMD

Back

Most recent

MDFA response to Federal Budget announcement 2025-26

Macular Disease Foundation Australia (MDFA) is pleased with the Federal Government’s increased investment to make primary health care more affordable and accessible for Australians doing it tough due to the current cost of living crisis.

Our latest edition of Vision Voice is here

Welcome to the latest edition of Vision Voice.

Government defers MBS private health insurance reclassification

Macular Disease Foundation Australia (MDFA) has welcomed the Federal Government’s decision to defer the private health insurance reclassification of intravitreal (eye) injections from 1 July 2025 to 1 July 2026 and undertake further consultation.

Call to Federal Government to bulk bill eye injections for pensioners

We have released new research in collaboration with the University of New South Wales which has revealed the median total cost for people living with macular disease, who also receive sight-saving eye injections, is 12 percent* ($3,621) of the annual government pension payment.

Opinion Editorial: Sight preservation should be a national priority

By The Hon. Jillian Skinner, AM, former NSW Minister for Health.This article was originally published by News Corp.

Living with macular disease consumes 12% of age pension payments

Macular Disease Foundation Australia calls on the next Federal Government to bulk-bill sight-saving eye injections for pensioners; with the potential for creating a $140 million cost-saving per year.

MDFA launches $200,000 grant for geographic atrophy research

Macular Disease Foundation Australia (MDFA) has announced the launch of its inaugural MDFA 25th Anniversary Award

New treatment for Geographic Atrophy

The Therapeutic Goods Administration (TGA) approval of the new eye injection treatment SYFOVRE® (pegcetacoplan) is welcome news, as it will give many people with Geographic Atrophy a treatment option that they’ve never had before to slow the progression of the disease.

Read our latest newsletter today

Welcome to our final Vision Voice newsletter for the year.

Exit Text Mode

MDFA News

New Nutrition Guidelines for AMD

Most recent

MDFA response to Federal Budget announcement 2025-26

Our latest edition of Vision Voice is here

Government defers MBS private health insurance reclassification

Call to Federal Government to bulk bill eye injections for pensioners

Opinion Editorial: Sight preservation should be a national priority

Living with macular disease consumes 12% of age pension payments

MDFA launches $200,000 grant for geographic atrophy research

New treatment for Geographic Atrophy

Read our latest newsletter today

Follow us

Newsletter sign-up

Thank you.
Your contact form has been successfully submitted.

Unfortunately there are no matches for your search.

Please try another search term.

Thank you for your order!

Your pack will be sent in the next two business days.

Your expression of interest in our research grants program has been submitted.

We will be in touch at the next stage of the process.

Thank you for referring to MDFA for non-clinical support and macular disease information. We will be in contact in 2-3 business days.

Thank you for referring to MDFA for non-clinical support and macular disease information. We will be in contact in 2-3 business days.

Thank you for subscribing to MDFA’s newsletter/s.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about MDFA’s newsletters:

Thank you for subscribing to our newsletter.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about Macular Disease Foundation’s newsletters:

Thank you for subscribing to our newsletter.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about Macular Disease Foundation’s newsletters:

Thank you for subscribing to our newsletter.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about Macular Disease Foundation’s newsletters:

Thank you for registering for this event.

Let people know you're attending:

The is for health professionals only. Please enter your organisation and practitioner type to subscribe. If you are not a health professional, please untick this newsletter to continue.

There are no items to display.

Please broaden your search.

MDFA News

New Nutrition Guidelines for AMD

Most recent

Follow us

Newsletter sign-up

Thank you.Your contact form has been successfully submitted.

Unfortunately there are no matches for your search.

Please try another search term.

Thank you for your order!

Your pack will be sent in the next two business days.

Your expression of interest in our research grants program has been submitted.

We will be in touch at the next stage of the process.

Thank you for referring to MDFA for non-clinical support and macular disease information. We will be in contact in 2-3 business days.

Thank you for referring to MDFA for non-clinical support and macular disease information. We will be in contact in 2-3 business days.

Thank you for subscribing to MDFA’s newsletter/s.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.Tell people about MDFA’s newsletters:

Thank you for subscribing to our newsletter.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.Tell people about Macular Disease Foundation’s newsletters:

Thank you for subscribing to our newsletter.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.Tell people about Macular Disease Foundation’s newsletters:

Thank you for subscribing to our newsletter.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.Tell people about Macular Disease Foundation’s newsletters:

Thank you for registering for this event.

Let people know you're attending:

The is for health professionals only. Please enter your organisation and practitioner type to subscribe. If you are not a health professional, please untick this newsletter to continue.

There are no items to display.

Please broaden your search.

Thank you.
Your contact form has been successfully submitted.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about MDFA’s newsletters:

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about Macular Disease Foundation’s newsletters:

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about Macular Disease Foundation’s newsletters:

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about Macular Disease Foundation’s newsletters: